In terms of workdays missed per patient during the 24-week study period, this did not reach statistical significance with the mean number (mean ± SD) being 6.8 ± 17.6 in the placebo group compared with 2.8 ± 13.3 in the infliximab group ( P = 0.07) [ 41 ].
1
0.0700
0.0700